Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Cutler

Psychiatry Lakewood Ranch, FL Medical Doctor

NPI 1063476125 CMS profile 649844

8429 Lorraine Rd Ste 350, Lakewood Ranch, FL 34202

Open in the dashboard

General payments

$5,694,991

5,347 records reported · program years 2019–2025

Research payments

$38,843

Paid to them · 41 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,416,238 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Andrew Cutler of Lakewood Ranch, FL is reported in the CMS Open Payments database as having received $5,694,991 across 5,347 general payments and $38,843 in research payments paid to them. Separately, studies naming them as principal investigator received $2,416,238 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,137,948 1,040
2024 General $1,095,695 993
2023 General $1,077,038 1,041
2022 General $851,287 806
2021 General $593,712 514
2020 General $385,841 324
2020 Research $762 1
2019 General $553,471 629
2019 Research $38,081 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Cutler
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Andrew Cutler were reported at $1,137,948. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Andrew Cutler Psychiatry median Middle half National median
2019 $553,471 $184 $59–$605 $163
2020 $385,841 $119 $36–$372 $114
2021 $593,712 $143 $43–$576 $132
2022 $851,287 $153 $50–$590 $149
2023 $1,077,038 $170 $56–$651 $160
2024 $1,095,695 $179 $57–$673 $164
2025 $1,137,948 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ITI, Inc. $763,304 624 payments
  2. AbbVie, Inc. $694,851 586 payments
  3. Teva Pharmaceuticals USA, Inc. $631,014 486 payments
  4. Alkermes, Inc. $625,342 621 payments
  5. Axsome Therapeutics, Inc. $484,712 432 payments
  6. Supernus Pharmaceuticals, Inc. $363,887 384 payments
  7. Neurocrine Biosciences, Inc. $327,309 320 payments
  8. Otsuka America Pharmaceutical, Inc. $234,919 303 payments
  9. Allergan Inc. $198,604 227 payments
  10. Janssen Pharmaceuticals, Inc $171,814 185 payments
  11. Other $1,199,235 1,179 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,584,799 1,173 payments
  2. Consulting Fee $1,161,775 328 payments
  3. Travel and Lodging $507,824 2,238 payments
  4. Honoraria $296,549 79 payments
  5. Food and Beverage $103,014 1,508 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $29,342 15 payments
  7. Education $8,651 4 payments
  8. Grant $3,035 2 payments
Products named General payments · program years 2019–2025
  1. CAPLYTA $614,484 506 payments
  2. VRAYLAR Neuroscience $539,158 465 payments
  3. Auvelity $456,628 411 payments
  4. AUSTEDO $408,185 288 payments
  5. LYBALVI Cns $341,019 353 payments
  6. LYBALVI Cns $330,355 331 payments
  7. LYBALVI Cns $330,235 329 payments
  8. LYBALVI Cns $330,235 329 payments
  9. VRAYLAR Neuroscience $313,443 297 payments
  10. ARISTADA $264,652 270 payments
  11. Other $3,277,241 3,401 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arbor Pharmaceuticals, Inc. $29,999 8 payments
  2. Otsuka Pharmaceutical Development & Commercialization, Inc. $4,495 5 payments
  3. Supernus Pharmaceuticals, Inc. $3,001 20 payments
  4. Neos Therapeutics, LP $1,345 7 payments
  5. Allergan Inc. $3 1 payment

Records

5,388 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record